Varian Medical‘s (NYSE:VAR) said today that the 1st patient has been treated with its HyperArc high definition radiotherapy system at Negrar-Verona, Italy’s Sacro Cuore Don Calabria Cancer Care Center. The Palo Alto, Calif.-based company’s HyperArc system is designed around its TrueBeam and Edge treatment platform, and delivers more compact radiation doses to fully saturate a […]
Radiosurgery/Radiation therapy
Ex-Medicare employees, traders deny insider trading charges
Former employees at the Centers for Medicare & Medicaid Services pleaded not guilty yesterday to charges that they used confidential information on Medicare reimbursement changes for radiation treatments and dialysis in a nearly $4 million insider trading scheme. Federal prosecutors last month accused political consultant David Blaszczak, founder of Precipio Health Strategies and the one-time colleague at CMS […]
Novocure gains on additional Optune data
Shares in Novocure (NSDQ:NVCR) are on the rise again after the company today cited additional data from a pivotal trial evaluating its Optune device with temozolomide chemotherapy as a treatment for newly-diagnosed glioblastoma. Novocure’s Optune mobile device delivers low-intensity, intermediate frequency, alternating electric fields, called “tumor treating fields” or TTFields, to inhibit cancer cell replication. Get […]
7 medtech stories we missed this week: April 7, 2017
New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate […]
Varian Medical, Elekta bury the hatchet in radiosurgery spat
Varian Medical (NYSE:VAR) and Elekta (STO:EKTA B) said yesterday that they agreed to bury the hatchet in their patent infringement war over radiosurgery technology. The agreement covers litigation in the U.S., Germany and the U.K. and includes a lawsuit brought by Elekta and William Beaumont Hospital in Royal Oak, Mich., Varian and Elekta said. The settlement did not involve […]
Elekta wins Health Canada nod for Leksell Gamma Knife Icon SRS system
Elekta (STO:EKTA B) said today it won Health Canada approval for its Leksell Gamma Knife Icon radiosurgery system. The Stockholm, Sweden-based company touted its Leksell Gamma Knife Icon radiosurgery system as the only SRS system designed specifically for targeting brain tissue. The Icon is the 6th generation version of the radiosurgery system from the Elekta. “Robust clinical […]
Monteris Medical raises $7m for NeuroBlate
Monteris Medical raised nearly $7 million of a hoped-for $10 million debt-and-options round for the NeuroBlate neurosurgery device it’s developing. Plymouth, Minn.-based Monteris last month won FDA approval for an investigational device exemption trial of NeuroBlate in patients newly diagnosed with a form of brain cancer called glioblastoma multiforme. The MRI-guided device is designed to ablate, necrotize or coagulate […]
FDA to docs: Don’t use Multidata’s radiation therapy devices
The FDA today released a warning over issues with devices manufactured by Multidata Systems International. The federal watchdog said it knows of “at least 2” Multidata medical devices that the company manufactures and distributes in the U.S. without appropriate clearance or review. The agency warned about issues with the Real Time Dosimetry Waterphantom System, and […]
Israeli technical institute takes a stake in NovoCure after patent settlement
A pair of Israeli technical institutes, the Technion Research and Development Foundation and the Technion – Israel Institute of Technology, agreed to accept a stake in NovoCure (NSDQ:NVCR) as part of a settlement inked last year to avert a potential patent dispute. The parties agreed in February 2015 to resolve “certain potential intellectual property disputes” between […]
Elekta touts MR-imaging radiotherapy combo at ASTRO
Richard Hausmann built his career on the physics of imaging – he spent 23 years at Siemens (NYSE:SI) and 4 years at GE (NYSE:GE) developing the magnetic resonance and computerized tomography businesses before joining Elekta (STO:EKTA B) as president & CEO in June 2016. Hausmann told MassDevice.com yesterday that Elekta’s new MR-linac system, which combines MR imaging […]
Accuray touts 5-year CyberKnife data in prostate cancer trial
Accuray (NSDQ:ARAY) today released 5-year data from a study of its CyberKnife stereotactic body radiotherapy device for treating prostate cancer, touting a 97% rate of freedom from cancer at 5 years. Results from the study were presented at the American Society for Therapeutic Radiology & Oncology’s annual meeting in Boston. The 21-site, 309-patient trial looked to examine […]